HomeCompareKAIIU vs JNJ

KAIIU vs JNJ: Dividend Comparison 2026

KAIIU yields 19.40% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KAIIU wins by $50.4K in total portfolio value
10 years
KAIIU
KAIIU
● Live price
19.40%
Share price
$10.31
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70.4K
Annual income
$6,316.72
Full KAIIU calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KAIIU vs JNJ

📍 KAIIU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKAIIUJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KAIIU + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KAIIU pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KAIIU
Annual income on $10K today (after 15% tax)
$1,648.88/yr
After 10yr DRIP, annual income (after tax)
$5,369.21/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KAIIU beats the other by $4,665.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KAIIU + JNJ for your $10,000?

KAIIU: 50%JNJ: 50%
100% JNJ50/50100% KAIIU
Portfolio after 10yr
$45.2K
Annual income
$3,572.25/yr
Blended yield
7.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KAIIU
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KAIIU buys
0
JNJ buys
0
No recent congressional trades found for KAIIU or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKAIIUJNJ
Forward yield19.40%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$70.4K$20.0K
Annual income after 10y$6,316.72$827.78
Total dividends collected$39.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KAIIU vs JNJ ($10,000, DRIP)

YearKAIIU PortfolioKAIIU Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,640$1,939.86$10,676$355.77+$2.0KKAIIU
2$15,816$2,291.55$11,407$389.39+$4.4KKAIIU
3$19,603$2,679.82$12,198$426.53+$7.4KKAIIU
4$24,080$3,104.18$13,056$467.62+$11.0KKAIIU
5$29,329$3,563.57$13,987$513.12+$15.3KKAIIU
6$35,438$4,056.44$14,998$563.56+$20.4KKAIIU
7$42,500$4,580.78$16,098$619.52+$26.4KKAIIU
8$50,609$5,134.16$17,295$681.69+$33.3KKAIIU
9$59,865$5,713.82$18,599$750.82+$41.3KKAIIU
10$70,372$6,316.72$20,022$827.78+$50.4KKAIIU

KAIIU vs JNJ: Complete Analysis 2026

KAIIUStock

Kismet Acquisition Two Corp. does not have significant operations. The company intends to acquire, engage in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchase all or substantially various assets of, or engage in any other similar initial business combination with one or more businesses or entities. Kismet Acquisition Two Corp. was incorporated in 2020 and is based in Newark, Delaware.

Full KAIIU Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KAIIU vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KAIIU vs SCHDKAIIU vs JEPIKAIIU vs OKAIIU vs KOKAIIU vs MAINKAIIU vs ABBVKAIIU vs MRKKAIIU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.